News

Neurona Therapeutics Raises $41.5M to Advance Neural Network-Rebalancing Cell Therapies for the Treatment of Epilepsy and other Neurological Disorders

Syndicate includes premier healthcare investors steeped in neurology Erica Whittaker, Ph.D., head of UCB Ventures, joins Neurona’s board of directors...

Allysta Pharmaceuticals, Inc. Announces Initiation of Dosing in OASIS-1 Phase 2b/3 Clinical Trial (ALY688-301 Study) Evaluating the Efficacy and Safety of ALY688 Ophthalmic Solution in Dry Eye

ALY688 Ophthalmic Solution advancing to pivotal studies based upon promising clinical safety and efficacy dataMulticenter US study to enroll subjects...

error: Content is protected !!